Venker's large open-market sale after a derivative exercise is the most informative trade in this cluster. Monitor for any upcoming negative catalyst (e.g., clinical trial readout for Immunovant, earnings miss, or guidance cut) that may have prompted the cash-out. The absence of a 10b5-1 plan elevates the bearish signal, but the modest size relative to market cap limits materiality.
Price Chart
Executive Summary
Roivant Sciences insiders executed $7.93M in net selling, dominated by President & Immunovant CEO Eric Venker's open-market sale of $7.32M following a derivative exercise. Director Melissa Epperly also sold $608K. The cluster is driven by Venker's large cash-out, which is not clearly plan-driven and represents ~0.3% of market cap, a modest but notable signal. Tax-withholding transactions by other executives are non-informative.
Key Financial Metrics
Key Facts
- President & Immunovant CEO Eric Venker sold 200,000 shares at $36.62 for $7.32M on 2026-09-30, following a derivative exercise at $3.85.
- Director Melissa Epperly sold 16,900 shares at $36.08 for $608K on 2026-10-01.
- Tax-withholding transactions by CEO Matthew Gline ($2.79M), President & CIO Mayukh Sukhatme ($1.71M), and President Frank Torti ($1.47M) are non-cash and non-informative.
- Total open-market selling of $7.93M represents approximately 0.3% of Roivant's market cap (based on $36.62 price and ~700M shares outstanding).
- Venker's sale is not flagged as 10b5-1 plan-driven, increasing its informational content.
Financial Impact
Open-market sales of $7.93M, ~0.3% of market cap; derivative exercise was non-cash.
Risk Factors
- Venker's sale may be liquidity-driven despite no 10b5-1 plan; further context needed.
- Tax-withholding transactions by other executives are routine and do not add bearish weight.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ROIV-1791237998630 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $36.80 | awaiting T+20 | — | $36.05 (−2.04%) |
Oct 5, 2026 21d ago | Insider Cluster | $35.53 | awaiting T+20 | — | $36.05 (−1.46%) |
Sep 17, 2026 5w ago | Insider Cluster | $39.77 $33.53 | ▼ −15.69% | ▼ −15.89% | $36.05 (−9.35%) |
Sep 17, 2026 5w ago | Insider Cluster | $39.77 $33.53 | ▼ −15.69% | ▼ −15.89% | $36.05 (−9.35%) |
Sep 17, 2026 5w ago | Insider Cluster | $39.77 $33.53 | ▼ −15.69% | ▼ −15.89% | $36.05 (−9.35%) |
Sep 1, 2026 7w ago | Insider Cluster | $34.18 $36.57 | ▲ +6.99% | ▲ +7.32% | $36.05 (+5.47%) |
Aug 27, 2026 8w ago | Press Release | $37.58 $36.13 | ▼ −3.86% | ▼ −3.35% | $36.05 (−4.07%) |
Aug 27, 2026 8w ago | Press Release | $37.58 $36.13 | ▼ −3.86% | ▼ −3.35% | $36.05 (−4.07%) |
Aug 26, 2026 8w ago | Press Release | $36.75 $38.99 | ▲ +6.10% | ▲ +4.89% | $36.05 (−1.90%) |
Aug 6, 2026 11w ago | 8-K | $35.12 $34.41 | ▼ −2.02% | ▼ −2.62% | $36.05 (+2.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers